NeonMind Reports Business Highlights on Partnership Activities, Clinical Pipeline and Corporate Developments Mar 10, 2022
NeonMind Announces Successful Completion of Pre-IND Consultation with FDA on Clinical Path for Obesity Drug Candidate… Nov 23, 2021
NeonMind Announces Corporate Update and Strategic Reorganization of its Pharmaceutical Division Aug 5, 2021